Shane Barton's most recent trade in BioAge Labs Inc. was a trade of 90,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAge Labs Inc. | Shane Barton | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Shane Barton | VP & Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 6,060 | 27,502 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Shane Barton | VP & Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 6,060 | 6,060 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Shane Barton | VP & Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 12,722 | 25,439 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Shane Barton | VP & Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 12,722 | 21,422 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Shane Barton | VP & Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 70,000 | 70,000 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Shane Barton | VP & Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 6,061 | 8,720 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Shane Barton | VP & Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 6,061 | 12,120 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Shane Barton | VP & Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 31,242 | 31,242 | - | - | Employee Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Shane Barton | VP & Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 18,181 | 18,181 | - | - | Restricted Stock Units |